Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Core EBITDA

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 9.987.267.948.955.32

What is the latest EV/Core EBITDA ratio of AUROBINDO PHARMA ?

The latest EV/Core EBITDA ratio of AUROBINDO PHARMA is 9.98 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20249.98
Mar20237.26
Mar20227.94
Mar20218.95
Mar20205.32

How is EV/Core EBITDA of AUROBINDO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 9.98
37.47
Mar2023 7.26
-8.56
Mar2022 7.94
-11.28
Mar2021 8.95
68.23
Mar2020 5.32 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Core EBITDA ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,472.7 Cr 3.9% -8.3% 1.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,569.0 Cr 2.8% -7.5% 2.3% Stock Analytics
DIVIS LABORATORIES ₹146,318.0 Cr -0.2% -9.9% 60.4% Stock Analytics
CIPLA ₹118,110.0 Cr 4.4% -0.6% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,926.0 Cr 4.8% -2.9% 15.4% Stock Analytics
DR REDDYS LABORATORIES ₹93,471.5 Cr NA -9.4% -10.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

3.9%

-8.3%

1.3%

SENSEX

1.4%

-5.3%

0.3%


You may also like the below Video Courses